Use Of Adipsin/complement Factor D In The Treatment Of Metabolic Related Disorders


The present invention relates to the field of metabolic research. Metabolic disorders, such as obesity, are a public health problem that is serious and widespread. Adipsin polypeptides have been identified that are believed to be beneficial in the treatment of metabolic disorders. These compounds should be effective for reducing body mass and for treating metabolic-related diseases and disorders. These metabolic-related diseases and disorders include hyperlipidemias, atherosclerosis, insulin resistance, diabetes, and hypertension.

Download PDF
Document Preview
Document History
  • Publication: Mar 15, 2005
  • Application: Jul 22, 2002
    US US 20267602 A
  • Priority: Jul 22, 2002
    US US 20267602 A
  • Priority: Jul 26, 2001
    US US 30814701 P

Download Citation

Sign in to the Lens